Maravai Lifesciences Holdings Inc Cash Flow Reinvestment Rate
Maravai Lifesciences Holdings Inc cash flow reinvestment rate. Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow Reinvestment Rate of 0.09x as of June 2026, reinvesting $370.00K (capex $370.00K ) from operating cash flow of $3.99 Million. Explore Maravai Lifesciences Holdings Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Maravai Lifesciences Holdings Inc (2019–2024)
Cash flow reinvestment rate of Maravai Lifesciences Holdings Inc from 2019 to 2024. Historical reinvestment intensity for Maravai Lifesciences Holdings Inc across 6 annual periods. Explore Maravai Lifesciences Holdings Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Maravai Lifesciences Holdings Inc Cash Flow Reinvestment Rate by Year (2019–2024)
Maravai Lifesciences Holdings Inc cash flow reinvestment rate by year from 2019 to 2024. Year-by-year capital reinvestment analysis for Maravai Lifesciences Holdings Inc. For the full cash flow conversion analysis, see MRVI cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.23x | $53.97 Million | $7.46 Million | $29.66 Million | ▲ +371.7% |
| 2023 | 1.53x | $193.48 Million | $126.22 Million | $65.55 Million | ▲ +188.6% |
| 2022 | 0.53x | $284.70 Million | $535.98 Million | $17.09 Million | ▲ +62.5% |
| 2021 | 0.33x | $120.50 Million | $368.57 Million | $14.85 Million | ▲ +58.1% |
| 2020 | 0.21x | $31.48 Million | $152.19 Million | $25.41 Million | ▼ -85.5% |
| 2019 | 1.42x | $34.30 Million | $24.11 Million | $17.15 Million | — |